chr6-159169697-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032532.3(FNDC1):c.101C>A(p.Ala34Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000995 in 1,004,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032532.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FNDC1 | NM_032532.3 | c.101C>A | p.Ala34Glu | missense_variant | 1/23 | ENST00000297267.14 | |
FNDC1-AS1 | NR_121668.1 | n.196+115G>T | intron_variant, non_coding_transcript_variant | ||||
FNDC1 | XM_011536190.3 | c.101C>A | p.Ala34Glu | missense_variant | 1/22 | ||
FNDC1 | XM_011536191.3 | c.101C>A | p.Ala34Glu | missense_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FNDC1 | ENST00000297267.14 | c.101C>A | p.Ala34Glu | missense_variant | 1/23 | 1 | NM_032532.3 | P1 | |
FNDC1-AS1 | ENST00000608986.1 | n.196+115G>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 9.95e-7 AC: 1AN: 1004926Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 474286
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2021 | The c.101C>A (p.A34E) alteration is located in exon 1 (coding exon 1) of the FNDC1 gene. This alteration results from a C to A substitution at nucleotide position 101, causing the alanine (A) at amino acid position 34 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at